Repligen Corp (RGEN)
131.41
-2.40%
Repligen Corp (RGEN) is currently trading at $131.41. This represents a loss of 2.4% from the previous session. With a market capitalization of $7.40B, RGEN is a key component of the Health Care sector. Investors looking to trade RGEN should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade RGEN commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Repligen Corp (RGEN) shows a bearish trend. Analysts are watching the 137.38 level closely.
Fundamentals
Mkt Cap7.40B
P/E Ratio0.0000
Volume742,801
60-Day Technical Chart
Advanced Charting
Need more indicators for RGEN? Use the world's #1 platform.
Open RGEN on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $131
| Metric |
RGEN -2.40% |
PLTR +4.42% |
WDAY +1.62% |
MSTR +9.82% |
|---|---|---|---|---|
| Price | $131.41 | $134.53 | $132.42 | $136.71 |
| Mkt Cap | $7.40B | $321.71B | $34.83B | $2.59B |
| - | View → | View → | View → |
Latest Headlines
Wells Fargo Lowers Price Target for RGEN, Maintains Overweight R
GuruFocus • Feb 25, 2026
$RGEN stock is down 8% today. Here's what we see in our data.
Quiver Quantitative • Feb 24, 2026
Repligen Corp (NASDAQ:RGEN) Stock Falls Despite Q4 Earnings Beat as 2026 Guidance Disappoints
ChartMill • Feb 24, 2026
Repligen Corporation (RGEN) Stock Analysis: Growth Momentum and a 40% Upside Potential
DirectorsTalk Interviews • Feb 23, 2026
Barclays Adjusts Repligen (RGEN) Target Price Amid Overweight Ra
GuruFocus • Feb 25, 2026
● Gemini Agentic AI Analyst Insight for RGEN
Market Education
- That suit said read and analyze Market trends. How ? Jul 18, 2023
- Understanding Hedge Fund Alpha and Beta: A Guide for New Investors Jun 2, 2024
- These Whales are taking all the Ape money - aka Large Fund Mgmt Companies Jul 17, 2023
External Research